Publications

5808 Results

E1411 Randomized Phase 2 Trial of Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma: Addition of Bortezomib to Front-Line BR Induction does not prolong PFS

Authors
MR Smith;O Jegede;P Martin;B Till;S Parekh;D Yang;L Kostakoglu Shields;C Casulo;N Bartlett;P Caimi;T Al Baghdadi;K Maddocks;M Romer;D Inwards;R Lerner;L Wagner;R Little;J Friedberg;J Leonard;B Kahl
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 7503) (American Society of Clinical Oncology Annual Meeting 2021, oral)
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/E1411

Dietary fat intake in relation to overall and progression-free survival among people with advanced or metastatic colorectal cancer: data from CALGB 80405

Authors
E Van Blarigan;C Ma;F-S Ou;A Venook;D Niedzwiecki;E Giovannucci;H-J Lenz;F Innocenti;J Shaw;B Polite;H Hochster;R Goldberg;R Mayer;CD Blanke;E O'Reilly;C Fuchs;J Meyerhardt
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 3588) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Granulomatous and sarcoid-like immune related adverse events (irAEs) in melanoma patients following CTLA4 blockade blockade adjuvant therapy: An analysis of 1670 high-risk patients

Authors
A Noor;I Nassine;S Lee;M Othus;J Moon;J Kirkwood;V Sondak;A Ribas;K Grossmann;A Tarhini
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 9582) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405

Authors
K DiNardo;S Zhang;F-S Ou;C Yuan;B Guerico;V Morales-Oyarvide;E Van Blarigan;D Niedzwiecki;I-Wen Chang;H-J Lenz;CD Blanke;A Venook;R Mayer;C Fuchs;F Innocenti;A Nixon;R Goldberg;E O'Reilly;J Meyerhardt
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 3568) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Phase III Comparison of High Dose Once-Daily (QD) Thoracic Radiotherapy (TRT) with Standard Twice-Daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance) / RTOG 0538

Authors
J Bogart;X Wang;G Masters;J Gao;R Komaki;L Gaspar;J Heymach;C Dobelbower;C Kuzma;T Stinchcombe;J Bradley;E Vokes
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 8505) (American Society of Clinical Oncology Annual Meeting 2021, oral)
Year
2021
Research Committee(s)
Lung

Association of Adiponectin with Tumor Infiltrating Lymphocytes in Patients with Stage III Colon Cancer Treated in an Adjuvant Chemotherapy Trial (NCCTG N0147, Alliance)

Authors
F Sinicrope;Q Shi;T Smyrk;R Goldberg;E Heying;S Cohen;S Gill;D Sha;Z Jin;M Kahlenberg;S Nair;A Shields;B Jahagirdar;N Foster;M Pollak;S Alberts
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 3591) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/N0147

S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma

Authors
SP Patel;M Othus;J Moon;M Tetzlaff;E Buchbinder;VK Sondak;M Lowe;K Mireles;E Sharon;L Korde;S Guild;W Carson;A Ribas;K Grossmann
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr TPS9585) (American Society of Clinical Oncology Annual Meeting 2021 (TIPS poster)
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
S1801

A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients: A trial of the ECOG-ACRIN Cancer Research Group (EA2176)

Authors
M Roth;P Catalana;K Ciombor;A Benson;X Yao;R Yaeger;M Salem;V Morris;D Henry;J Whisenant;P O'Dwyer;C Eng
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr TPS3614) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/EA2176

Baseline and short-term financial burden (FB) in colorectal cancer (CRC) treated with curative intent: early results of ECOG-ACRIN EAQ162CD

Authors
S Kircher;F Duan;I Gareen;E Underwood;J Sicks;J Suga;H Kehn;P Mehan;J Acoba;M Taylor;L Wagner;R Carlos
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 1518) (American Society of Clinical Oncology Annual Meeting 2021, poster discussion session)
Year
2021
Research Committee(s)
Cancer Care Delivery

Prospective Validation of Genetic Predictors of Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS) in a Racially Diverse Cohort: Results from ECOG-ACRIN E1Z11

Authors
V Stearns;O Jegede;V Chang;T Skaar;J Berenberg;R Nand;A Lyss;N Jacobs;W Luginbuhl;P Gilman;A Benson;J Goodman;G Buchschacher;NL Henry;C Loprinzi;P Flynn;E Mitchell;MJ Fisch;J Sparano;L Wagner
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 12003) (American Society of Clinical Oncology Annual Meeting 2021, oral)
Year
2021
Research Committee(s)
Breast
Study Number(s)
CTSU/E1Z11